BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9051045)

  • 1. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings.
    Lee CH; Egglin TK; Philpotts L; Mainiero MB; Tocino I
    Radiology; 1997 Mar; 202(3):849-54. PubMed ID: 9051045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of stereotaxic core breast biopsy on cost of diagnosis.
    Liberman L; Fahs MC; Dershaw DD; Bonaccio E; Abramson AF; Cohen MA; Hann LE
    Radiology; 1995 Jun; 195(3):633-7. PubMed ID: 7753986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic core biopsy of calcifications highly suggestive of malignancy.
    Liberman L; LaTrenta LR; Van Zee KJ; Morris EA; Abramson AF; Dershaw DD
    Radiology; 1997 Jun; 203(3):673-7. PubMed ID: 9169687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of stereotactic biopsy in assessment of nonpalpable breast lesions.
    Wallace JE; Sayler C; McDowell NG; Moseley HS
    Am J Surg; 1996 May; 171(5):471-3. PubMed ID: 8651387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of Core Biopsy for BI-RADS-5 Breast Lesions.
    Wolf R; Quan G; Calhoun K; Soot L; Skokan L
    Breast J; 2008; 14(5):471-5. PubMed ID: 18821933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy.
    Liberman L; Sama MP
    AJR Am J Roentgenol; 2000 Jul; 175(1):53-8. PubMed ID: 10882245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of stereotactic vacuum-assisted biopsy for nonpalpable breast lesions.
    Tsai HY; Huang ST; Chao MF; Kan JY; Hsu JS; Hou MF; Chiu HC
    Eur J Radiol; 2020 Jun; 127():108982. PubMed ID: 32334370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
    Kirshenbaum KJ; Voruganti T; Overbeeke C; Kirshenbaum MD; Patel P; Kaplan G; Maker V; August C; Cavallino RP
    AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic fine needle aspiration of mammographic lesions.
    Pressler V; Namiki T; Cieply J; Matsuoka J; Nakashizuka M; Tauchi P; Bernice M; Oishi K
    J Am Coll Surg; 1994 Jan; 178(1):54-8. PubMed ID: 8156118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US-guided core breast biopsy: use and cost-effectiveness.
    Liberman L; Feng TL; Dershaw DD; Morris EA; Abramson AF
    Radiology; 1998 Sep; 208(3):717-23. PubMed ID: 9722851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic breast biopsy is accurate, minimally invasive, and cost effective.
    Pettine S; Place R; Babu S; Williard W; Kim D; Carter P
    Am J Surg; 1996 May; 171(5):474-6. PubMed ID: 8651388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.
    Hillner BE; Bear HD; Fajardo LL
    Acad Radiol; 1996 Apr; 3(4):351-60. PubMed ID: 8796686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.
    Groenewoud JH; Pijnappel RM; van den Akker-Van Marle ME; Birnie E; Buijs-van der Woude T; Mali WP; de Koning HJ; Buskens E
    Br J Cancer; 2004 Jan; 90(2):383-92. PubMed ID: 14735181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic breast biopsy as an alternative to open excisional biopsy.
    Cross MJ; Evans WP; Peters GN; Cheek JH; Jones RC; Krakos P
    Ann Surg Oncol; 1995 May; 2(3):195-200. PubMed ID: 7641014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer.
    Lind DS; Minter R; Steinbach B; Abbitt P; Lanier L; Haigh L; Vauthey JN; Russin M; Hackett R; Copeland EM
    J Surg Res; 1998 Jul; 78(1):23-6. PubMed ID: 9733612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique.
    Seoudi H; Mortier J; Basile R; Curletti E
    Arch Surg; 1998 Apr; 133(4):366-72. PubMed ID: 9565115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of stereotactic breast biopsy.
    Bernstein JR
    Semin Surg Oncol; 1996; 12(5):290-9. PubMed ID: 8873316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions; discussion 994-5.
    Fahy BN; Bold RJ; Schneider PD; Khatri V; Goodnight JE
    Arch Surg; 2001 Sep; 136(9):990-4. PubMed ID: 11529819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.
    Mikhail RA; Nathan RC; Weiss M; Tummala RM; Mullangi UR; Lawrence L; Mukkamala A
    Ann Surg Oncol; 1994 Sep; 1(5):363-7. PubMed ID: 7850536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.